PHPB2B 'q' Parameter Cross Site Scripting Vulnerability
BID:51221
Info
PHPB2B 'q' Parameter Cross Site Scripting Vulnerability
| Bugtraq ID: | 51221 |
| Class: | Input Validation Error |
| CVE: | |
| Remote: | Yes |
| Local: | No |
| Published: | Jan 01 2012 12:00AM |
| Updated: | Jan 01 2012 12:00AM |
| Credit: | H4ckCity Security Team |
| Vulnerable: |
PHPB2B PHPB2B 4.1 PHPB2B PHPB2B 0 |
| Not Vulnerable: | |
Discussion
PHPB2B 'q' Parameter Cross Site Scripting Vulnerability
PHPB2B is prone to a cross-site-scripting vulnerability because it fails to properly sanitize user-supplied input.
An attacker may leverage this issue to execute arbitrary script code in the browser of an unsuspecting user in the context of the affected site. This can allow the attacker to steal cookie-based authentication credentials and launch other attacks.
PHPB2B is prone to a cross-site-scripting vulnerability because it fails to properly sanitize user-supplied input.
An attacker may leverage this issue to execute arbitrary script code in the browser of an unsuspecting user in the context of the affected site. This can allow the attacker to steal cookie-based authentication credentials and launch other attacks.
Exploit / POC
PHPB2B 'q' Parameter Cross Site Scripting Vulnerability
Attackers can exploit this issue by enticing an unsuspecting victim to follow a malicious URI.
The following example URI is available:
http://www.example.com/[patch]/list.php?do=search&q=[XSS]
Attackers can exploit this issue by enticing an unsuspecting victim to follow a malicious URI.
The following example URI is available:
http://www.example.com/[patch]/list.php?do=search&q=[XSS]
Solution / Fix
PHPB2B 'q' Parameter Cross Site Scripting Vulnerability
Solution:
Currently, we are not aware of any vendor-supplied patches. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected].
Solution:
Currently, we are not aware of any vendor-supplied patches. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected].